No., subject, TM-score, RMSD, Sequence Identity, Subject length, Aligned length, Description
1, 3ezqN, 1.0000, 0.00, 1.000, 99, 99, CRYSTAL STRUCTURE OF THE FAS/FADD DEATH DOMAIN COMPLEX
2, 3ezqL, 0.9999, 0.03, 1.000, 99, 99, CRYSTAL STRUCTURE OF THE FAS/FADD DEATH DOMAIN COMPLEX
3, 3ezqF, 0.9999, 0.03, 1.000, 99, 99, CRYSTAL STRUCTURE OF THE FAS/FADD DEATH DOMAIN COMPLEX
4, 3ezqD, 0.9999, 0.02, 1.000, 99, 99, CRYSTAL STRUCTURE OF THE FAS/FADD DEATH DOMAIN COMPLEX
5, 3ezqP, 0.9998, 0.04, 1.000, 99, 99, CRYSTAL STRUCTURE OF THE FAS/FADD DEATH DOMAIN COMPLEX
6, 3ezqJ, 0.9998, 0.04, 1.000, 99, 99, CRYSTAL STRUCTURE OF THE FAS/FADD DEATH DOMAIN COMPLEX
7, 3ezqH, 0.9998, 0.04, 1.000, 99, 99, CRYSTAL STRUCTURE OF THE FAS/FADD DEATH DOMAIN COMPLEX
8, 3ezqB, 0.9998, 0.04, 1.000, 99, 99, CRYSTAL STRUCTURE OF THE FAS/FADD DEATH DOMAIN COMPLEX
9, 3oq9L, 0.9263, 0.21, 1.000, 92, 92, STRUCTURE OF THE FAS/FADD DEATH DOMAIN ASSEMBLY
10, 3oq9K, 0.9263, 0.21, 1.000, 92, 92, STRUCTURE OF THE FAS/FADD DEATH DOMAIN ASSEMBLY
11, 3oq9J, 0.9263, 0.21, 1.000, 92, 92, STRUCTURE OF THE FAS/FADD DEATH DOMAIN ASSEMBLY
12, 3oq9I, 0.9263, 0.21, 1.000, 92, 92, STRUCTURE OF THE FAS/FADD DEATH DOMAIN ASSEMBLY
13, 3oq9H, 0.9263, 0.21, 1.000, 92, 92, STRUCTURE OF THE FAS/FADD DEATH DOMAIN ASSEMBLY
14, 2of5K, 0.7897, 1.93, 0.239, 100, 92, OLIGOMERIC DEATH DOMAIN COMPLEX
15, 2of5I, 0.7868, 1.94, 0.239, 100, 92, OLIGOMERIC DEATH DOMAIN COMPLEX
16, 4o6xA, 0.7864, 2.03, 0.231, 98, 91, CRYSTAL STRUCTURE OF HUMAN ANKYRIN G DEATH DOMAIN
17, 2of5L, 0.7852, 1.95, 0.239, 100, 92, OLIGOMERIC DEATH DOMAIN COMPLEX
18, 2yqfA, 0.7843, 1.56, 0.261, 111, 88, SOLUTION STRUCTURE OF THE DEATH DOMAIN OF ANKYRIN-1
19, 2yviA, 0.7832, 1.30, 0.294, 89, 85, CRYSTAL STRUCTURE OF A DEATH DOMAIN OF HUMAN ANKRYN PROTEIN
20, 4o6xB, 0.7819, 1.86, 0.233, 95, 90, CRYSTAL STRUCTURE OF HUMAN ANKYRIN G DEATH DOMAIN
21, 2of5J, 0.7776, 2.06, 0.239, 100, 92, OLIGOMERIC DEATH DOMAIN COMPLEX
22, 2of5H, 0.7753, 2.08, 0.239, 100, 92, OLIGOMERIC DEATH DOMAIN COMPLEX
23, 1e3yA, 0.7548, 2.39, 0.990, 104, 96, DEATH DOMAIN FROM HUMAN FADD/MORT1
24, 2of5D, 0.7436, 1.77, 0.209, 91, 86, OLIGOMERIC DEATH DOMAIN COMPLEX
25, 2of5F, 0.7422, 1.80, 0.209, 91, 86, OLIGOMERIC DEATH DOMAIN COMPLEX
26, 2of5E, 0.7420, 2.16, 0.207, 91, 87, OLIGOMERIC DEATH DOMAIN COMPLEX
27, 2of5C, 0.7419, 1.77, 0.209, 91, 86, OLIGOMERIC DEATH DOMAIN COMPLEX
28, 2of5B, 0.7406, 1.81, 0.209, 91, 86, OLIGOMERIC DEATH DOMAIN COMPLEX
29, 2of5A, 0.7405, 1.80, 0.209, 91, 86, OLIGOMERIC DEATH DOMAIN COMPLEX
30, 1e41A, 0.7392, 2.24, 0.957, 104, 93, DEATH DOMAIN FROM HUMAN FADD/MORT1
31, 2o71A, 0.7375, 1.81, 0.209, 91, 86, CRYSTAL STRUCTURE OF RAIDD DD
32, 1wxpA, 0.7336, 1.99, 0.233, 110, 86, SOLUTION STRUCTURE OF THE DEATH DOMAIN OF NUCLEAR MATRIX PROTEIN P84
33, 1d2zB, 0.7217, 2.33, 0.165, 150, 91, THREE-DIMENSIONAL STRUCTURE OF A COMPLEX BETWEEN THE DEATH DOMAINS OF PELLE AND TUBE
34, 2of5G, 0.7215, 1.93, 0.209, 91, 86, OLIGOMERIC DEATH DOMAIN COMPLEX
35, 4d8oA, 0.7124, 1.26, 0.244, 509, 78, CRYSTAL STRUCTURE OF THE ANKYRIN-B ZU5-ZU5-UPA-DD TANDEM
36, 1d2zD, 0.7112, 2.49, 0.154, 153, 91, THREE-DIMENSIONAL STRUCTURE OF A COMPLEX BETWEEN THE DEATH DOMAINS OF PELLE AND TUBE
37, 5xmeA, 0.7063, 2.30, 0.253, 114, 91, SOLUTION STRUCTURE OF C-TERMINAL DOMAIN OF TRADD
38, 1ddfA, 0.7055, 2.86, 0.143, 127, 98, FAS DEATH DOMAIN NMR MINIMIZED AVERAGE STRUCTURE
39, 4izaB, 0.7039, 2.15, 0.071, 95, 85, STRUCTURE OF DUALLY PHOSPHORYLATED ERK2 BOUND TO THE PEA-15 DEATH EFFECTOR DOMAIN
40, 3mopE, 0.7015, 2.53, 0.156, 105, 90, THE TERNARY DEATH DOMAIN COMPLEX OF MYD88 IRAK4 AND IRAK2
41, 3mopD, 0.7015, 2.53, 0.156, 105, 90, THE TERNARY DEATH DOMAIN COMPLEX OF MYD88 IRAK4 AND IRAK2
42, 3mopC, 0.6982, 2.55, 0.156, 105, 90, THE TERNARY DEATH DOMAIN COMPLEX OF MYD88 IRAK4 AND IRAK2
43, 3mopA, 0.6982, 2.39, 0.156, 105, 90, THE TERNARY DEATH DOMAIN COMPLEX OF MYD88 IRAK4 AND IRAK2
44, 3mopB, 0.6981, 2.39, 0.156, 105, 90, THE TERNARY DEATH DOMAIN COMPLEX OF MYD88 IRAK4 AND IRAK2
45, 3mopF, 0.6978, 2.55, 0.156, 105, 90, THE TERNARY DEATH DOMAIN COMPLEX OF MYD88 IRAK4 AND IRAK2
46, 1ichA, 0.6925, 1.94, 0.259, 87, 85, SOLUTION STRUCTURE OF THE TUMOR NECROSIS FACTOR RECEPTOR-1 DEATH DOMAIN
47, 1fadA, 0.6835, 2.46, 0.611, 95, 90, DEATH DOMAIN OF FAS-ASSOCIATED DEATH DOMAIN PROTEIN RESIDUES 89-183
48, 3mopK, 0.6830, 2.36, 0.209, 93, 86, THE TERNARY DEATH DOMAIN COMPLEX OF MYD88 IRAK4 AND IRAK2
49, 3mopM, 0.6828, 2.36, 0.209, 93, 86, THE TERNARY DEATH DOMAIN COMPLEX OF MYD88 IRAK4 AND IRAK2
50, 3mopN, 0.6817, 2.36, 0.209, 93, 86, THE TERNARY DEATH DOMAIN COMPLEX OF MYD88 IRAK4 AND IRAK2
51, 3mopL, 0.6816, 2.36, 0.209, 93, 86, THE TERNARY DEATH DOMAIN COMPLEX OF MYD88 IRAK4 AND IRAK2
52, 1n3kA, 0.6797, 2.28, 0.081, 130, 86, SOLUTION STRUCTURE OF PHOSPHOPROTEIN ENRICHED IN ASTROCYTES 15 KDA (PEA-15)
53, 2ls7A, 0.6774, 2.29, 0.082, 90, 85, HIGH DEFINITION SOLUTION STRUCTURE OF PED/PEA-15 DEATH EFFECTOR DOMAIN
54, 1d2zA, 0.6774, 2.63, 0.184, 102, 87, THREE-DIMENSIONAL STRUCTURE OF A COMPLEX BETWEEN THE DEATH DOMAINS OF PELLE AND TUBE
55, 5wvcD, 0.6756, 2.58, 0.140, 102, 93, STRUCTURE OF THE CARD-CARD DISK
56, 2n80A, 0.6748, 2.60, 0.227, 94, 88, P75NTR DD:RHOGDI
57, 1d2zC, 0.6740, 2.36, 0.174, 108, 86, THREE-DIMENSIONAL STRUCTURE OF A COMPLEX BETWEEN THE DEATH DOMAINS OF PELLE AND TUBE
58, 2dbfA, 0.6730, 2.00, 0.146, 100, 82, SOLUTION STRUCTURE OF THE DEATH DOMAIN IN HUMAN NUCLEAR FACTOR NF-KAPPA-B P105 SUBUNIT
59, 1ygoA, 0.6715, 2.58, 0.184, 110, 87, SOLUTION STRUCTURE OF THE PELLE DEATH DOMAIN
60, 4iz7B, 0.6698, 2.41, 0.095, 90, 84, STRUCTURE OF NON-PHOSPHORYLATED ERK2 BOUND TO THE PEA-15 DEATH EFFECTOR DOMAIN
61, 2a9iA, 0.6694, 2.12, 0.207, 105, 82, MOLECULAR STRUCTURE OF THE INTERLEUKIN-1 RECEPTOR- ASSOCIATED KINASE-4 DEATH DOMAIN
62, 5wvcB, 0.6689, 2.65, 0.140, 102, 93, STRUCTURE OF THE CARD-CARD DISK
63, 2bbzA, 0.6685, 2.68, 0.140, 190, 86, CRYSTAL STRUCTURE OF MC159 REVEALS MOLECULAR MECHANISM OF DISC ASSEMBLY AND VFLIP INHIBITION
64, 2bbzC, 0.6683, 2.68, 0.140, 190, 86, CRYSTAL STRUCTURE OF MC159 REVEALS MOLECULAR MECHANISM OF DISC ASSEMBLY AND VFLIP INHIBITION
65, 2bbzD, 0.6682, 2.68, 0.140, 190, 86, CRYSTAL STRUCTURE OF MC159 REVEALS MOLECULAR MECHANISM OF DISC ASSEMBLY AND VFLIP INHIBITION
66, 2bbzB, 0.6679, 2.69, 0.140, 190, 86, CRYSTAL STRUCTURE OF MC159 REVEALS MOLECULAR MECHANISM OF DISC ASSEMBLY AND VFLIP INHIBITION
67, 1wh4A, 0.6677, 2.33, 0.205, 127, 83, SOLUTION STRUCTURE OF THE DEATH DOMAIN OF INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASE4 (IRAK4) FROM MUS MUSCULUS
68, 5wvcF, 0.6674, 2.72, 0.140, 102, 93, STRUCTURE OF THE CARD-CARD DISK
69, 3mopI, 0.6670, 2.44, 0.205, 107, 83, THE TERNARY DEATH DOMAIN COMPLEX OF MYD88 IRAK4 AND IRAK2
70, 3mopJ, 0.6663, 2.39, 0.229, 107, 83, THE TERNARY DEATH DOMAIN COMPLEX OF MYD88 IRAK4 AND IRAK2
71, 3mopH, 0.6658, 2.40, 0.229, 107, 83, THE TERNARY DEATH DOMAIN COMPLEX OF MYD88 IRAK4 AND IRAK2
72, 3mopG, 0.6658, 2.40, 0.229, 107, 83, THE TERNARY DEATH DOMAIN COMPLEX OF MYD88 IRAK4 AND IRAK2
73, 2a5yB, 0.6649, 2.74, 0.152, 501, 92, STRUCTURE OF A CED-4/CED-9 COMPLEX
74, 3lqqB, 0.6608, 2.62, 0.167, 501, 90, STRUCTURE OF THE CED-4 APOPTOSOME
75, 4rhwF, 0.6607, 2.27, 0.115, 95, 87, CRYSTAL STRUCTURE OF APAF-1 CARD AND CASPASE-9 CARD COMPLEX
76, 5wveY, 0.6598, 2.39, 0.103, 95, 87, APAF-1-CASPASE-9 HOLOENZYME
77, 5juyR, 0.6598, 2.39, 0.103, 95, 87, ACTIVE HUMAN APOPTOSOME WITH PROCASPASE-9
78, 5juyQ, 0.6598, 2.39, 0.103, 95, 87, ACTIVE HUMAN APOPTOSOME WITH PROCASPASE-9
79, 5juyP, 0.6598, 2.39, 0.103, 95, 87, ACTIVE HUMAN APOPTOSOME WITH PROCASPASE-9
80, 5juyO, 0.6598, 2.39, 0.103, 95, 87, ACTIVE HUMAN APOPTOSOME WITH PROCASPASE-9
81, 4rhwE, 0.6598, 2.39, 0.103, 95, 87, CRYSTAL STRUCTURE OF APAF-1 CARD AND CASPASE-9 CARD COMPLEX
82, 3lqrB, 0.6541, 2.79, 0.154, 501, 91, STRUCTURE OF CED-4:CED-3 COMPLEX
83, 3lqqA, 0.6534, 2.65, 0.157, 503, 89, STRUCTURE OF THE CED-4 APOPTOSOME
84, 3oq9C, 0.6533, 2.36, 0.174, 86, 86, STRUCTURE OF THE FAS/FADD DEATH DOMAIN ASSEMBLY
85, 3oq9A, 0.6533, 2.36, 0.174, 86, 86, STRUCTURE OF THE FAS/FADD DEATH DOMAIN ASSEMBLY
86, 3oq9E, 0.6532, 2.36, 0.174, 86, 86, STRUCTURE OF THE FAS/FADD DEATH DOMAIN ASSEMBLY
87, 3oq9D, 0.6532, 2.36, 0.174, 86, 86, STRUCTURE OF THE FAS/FADD DEATH DOMAIN ASSEMBLY
88, 3oq9B, 0.6531, 2.36, 0.174, 86, 86, STRUCTURE OF THE FAS/FADD DEATH DOMAIN ASSEMBLY
89, 3lqrA, 0.6514, 2.55, 0.159, 503, 88, STRUCTURE OF CED-4:CED-3 COMPLEX
90, 5ukeA, 0.6513, 3.16, 0.239, 124, 88, NMR STRUCTURE OF MONOMERIC HUMAN IRAK-M DEATH DOMAIN R56D Y61E MUTANT
91, 2bbrA, 0.6500, 2.82, 0.151, 189, 86, CRYSTAL STRUCTURE OF MC159 REVEALS MOLECULAR MECHANISM OF DISC ASSEMBLY AND VFLIP INHIBITION
92, 2d96A, 0.6496, 2.43, 0.183, 109, 82, SOLUTION STRUCTURE OF THE DEATH DOMAIN OF NUCLEAR FACTOR NF- KAPPA-B P100
93, 4f44B, 0.6489, 2.13, 0.250, 83, 80, NEUROTROPHIN P75NTR INTRACELLULAR DOMAIN
94, 4m9xA, 0.6468, 2.70, 0.182, 510, 88, CRYSTAL STRUCTURE OF CED-4 BOUND CED-3 FRAGMENT
95, 4f42A, 0.6461, 2.22, 0.237, 84, 80, NEUROTROPHIN P75NTR INTRACELLULAR DOMAIN
96, 4f44A, 0.6452, 2.15, 0.250, 83, 80, NEUROTROPHIN P75NTR INTRACELLULAR DOMAIN
97, 4n1lA, 0.6408, 2.53, 0.071, 95, 85, CRYSTAL STRUCTURES OF NLRP14 PYRIN DOMAIN REVEAL A CONFORMATIONAL SWITCH MECHANISM REGULATING ITS MOLECULAR INTERACTIONS
98, 6bzeE, 0.6397, 2.86, 0.088, 106, 91, CRYO-EM STRUCTURE OF BCL10 CARD FILAMENT
99, 6bzeG, 0.6392, 2.93, 0.088, 106, 91, CRYO-EM STRUCTURE OF BCL10 CARD FILAMENT
100, 6bzeD, 0.6389, 2.93, 0.099, 106, 91, CRYO-EM STRUCTURE OF BCL10 CARD FILAMENT
101, 1wmgC, 0.6381, 1.87, 0.171, 84, 76, CRYSTAL STRUCTURE OF THE UNC5H2 DEATH DOMAIN
102, 6bzeC, 0.6378, 2.93, 0.099, 106, 91, CRYO-EM STRUCTURE OF BCL10 CARD FILAMENT
103, 6bzeH, 0.6375, 2.94, 0.099, 106, 91, CRYO-EM STRUCTURE OF BCL10 CARD FILAMENT
104, 6bzeF, 0.6375, 2.94, 0.088, 106, 91, CRYO-EM STRUCTURE OF BCL10 CARD FILAMENT
105, 6bzeA, 0.6374, 2.94, 0.088, 106, 91, CRYO-EM STRUCTURE OF BCL10 CARD FILAMENT
106, 4v4lP, 0.6369, 3.02, 0.088, 1215, 91, 
107, 4v4lO, 0.6369, 3.02, 0.088, 1215, 91, 
108, 4v4lN, 0.6369, 3.02, 0.088, 1215, 91, 
109, 4v4lM, 0.6369, 3.02, 0.088, 1215, 91, 
110, 4v4lL, 0.6369, 3.02, 0.088, 1215, 91, 
111, 4v4lK, 0.6369, 3.02, 0.088, 1215, 91, 
112, 4v4lJ, 0.6369, 3.02, 0.088, 1215, 91, 
113, 4v4lI, 0.6369, 3.02, 0.088, 1215, 91, 
114, 4v4lH, 0.6369, 3.02, 0.088, 1215, 91, 
115, 4v4lG, 0.6369, 3.02, 0.088, 1215, 91, 
116, 4v4lF, 0.6369, 3.02, 0.088, 1215, 91, 
117, 4v4lE, 0.6369, 3.02, 0.088, 1215, 91, 
118, 4v4lD, 0.6369, 3.02, 0.088, 1215, 91, 
119, 4v4lC, 0.6369, 3.02, 0.088, 1215, 91, 
120, 4v4lB, 0.6369, 3.02, 0.088, 1215, 91, 
121, 4v4lA, 0.6369, 3.02, 0.088, 1215, 91, 
122, 4p4hA, 0.6348, 2.66, 0.092, 188, 87, CAUGHT-IN-ACTION SIGNALING COMPLEX OF RIG-I 2CARD DOMAIN AND MAVS CARD DOMAIN
123, 6bzeB, 0.6347, 2.89, 0.088, 106, 91, CRYO-EM STRUCTURE OF BCL10 CARD FILAMENT
124, 4p4hE, 0.6338, 2.66, 0.092, 188, 87, CAUGHT-IN-ACTION SIGNALING COMPLEX OF RIG-I 2CARD DOMAIN AND MAVS CARD DOMAIN
125, 1ngrA, 0.6329, 2.37, 0.235, 85, 81, DEATH DOMAIN OF P75 LOW AFFINITY NEUROTROPHIN RECEPTOR RESIDUES 334-418 NMR 20 STRUCTURES
126, 2n97B, 0.6324, 2.40, 0.244, 94, 82, DD HOMODIMER
127, 2n97A, 0.6313, 2.45, 0.238, 94, 84, DD HOMODIMER
128, 4m9yA, 0.6295, 3.16, 0.151, 493, 93, CRYSTAL STRUCTURE OF CED-4 BOUND CED-3 FRAGMENT
129, 4m9xB, 0.6283, 2.94, 0.151, 511, 93, CRYSTAL STRUCTURE OF CED-4 BOUND CED-3 FRAGMENT
130, 5wveU, 0.6280, 2.91, 0.078, 96, 90, APAF-1-CASPASE-9 HOLOENZYME
131, 4m9zC, 0.6280, 3.14, 0.151, 493, 93, CRYSTAL STRUCTURE OF CED-4 BOUND CED-3 FRAGMENT
132, 4m9sD, 0.6280, 2.92, 0.152, 494, 92, CRYSTAL STRUCTURE OF CED-4 BOUND CED-3 FRAGMENT
133, 4m9zD, 0.6277, 2.87, 0.152, 494, 92, CRYSTAL STRUCTURE OF CED-4 BOUND CED-3 FRAGMENT
134, 2f1sA, 0.6276, 2.68, 0.146, 177, 82, CRYSTAL STRUCTURE OF A VIRAL FLIP MC159
135, 4m9sA, 0.6271, 3.10, 0.152, 493, 92, CRYSTAL STRUCTURE OF CED-4 BOUND CED-3 FRAGMENT
136, 4m9sC, 0.6265, 3.09, 0.152, 493, 92, CRYSTAL STRUCTURE OF CED-4 BOUND CED-3 FRAGMENT
137, 4nqkD, 0.6264, 2.77, 0.103, 188, 87, STRUCTURE OF AN UBIQUITIN COMPLEX
138, 4m9sB, 0.6259, 2.77, 0.154, 494, 91, CRYSTAL STRUCTURE OF CED-4 BOUND CED-3 FRAGMENT
139, 5wveT, 0.6257, 2.91, 0.067, 96, 90, APAF-1-CASPASE-9 HOLOENZYME
140, 4m9yB, 0.6253, 2.89, 0.152, 494, 92, CRYSTAL STRUCTURE OF CED-4 BOUND CED-3 FRAGMENT
141, 1dgnA, 0.6252, 2.61, 0.120, 89, 83, SOLUTION STRUCTURE OF ICEBERG AN INHIBITOR OF INTERLEUKIN- 1BETA GENERATION
142, 4m9zA, 0.6250, 3.06, 0.163, 493, 92, CRYSTAL STRUCTURE OF CED-4 BOUND CED-3 FRAGMENT
143, 4m9zB, 0.6247, 2.78, 0.154, 494, 91, CRYSTAL STRUCTURE OF CED-4 BOUND CED-3 FRAGMENT
144, 6bzhE, 0.6241, 2.97, 0.114, 191, 88, STRUCTURE OF MOUSE RIG-I TANDEM CARDS
145, 4dwnA, 0.6230, 2.55, 0.120, 96, 83, CRYSTAL STRUCTURE OF HUMAN BINCARD CARD
146, 3g5bA, 0.6229, 2.75, 0.171, 383, 82, THE STRUCTURE OF UNC5B CYTOPLASMIC DOMAIN
147, 4nqkA, 0.6225, 2.80, 0.103, 188, 87, STRUCTURE OF AN UBIQUITIN COMPLEX
148, 6bzhC, 0.6216, 2.95, 0.114, 191, 88, STRUCTURE OF MOUSE RIG-I TANDEM CARDS
149, 2dbgA, 0.6215, 2.96, 0.069, 103, 87, SOLUTION STRUCTURE OF THE PYRIN (PAAD-DAPIN) DOMAIN IN HUMAN MYELOID CELL NUCLEAR DIFFERENTIATION ANTIGEN
150, 2mb9A, 0.6213, 3.28, 0.128, 106, 94, HUMAN BCL10 CARD
151, 4dwnB, 0.6212, 2.55, 0.120, 95, 83, CRYSTAL STRUCTURE OF HUMAN BINCARD CARD
152, 5wveV, 0.6205, 2.95, 0.067, 96, 90, APAF-1-CASPASE-9 HOLOENZYME
153, 5wveS, 0.6205, 2.95, 0.067, 96, 90, APAF-1-CASPASE-9 HOLOENZYME
154, 4nqkB, 0.6205, 3.01, 0.102, 188, 88, STRUCTURE OF AN UBIQUITIN COMPLEX
155, 3ygsP, 0.6205, 2.95, 0.067, 97, 90, APAF-1 CARD IN COMPLEX WITH PRODOMAIN OF PROCASPASE-9
156, 1wmgE, 0.6199, 2.02, 0.171, 84, 76, CRYSTAL STRUCTURE OF THE UNC5H2 DEATH DOMAIN
157, 4p4hG, 0.6196, 2.76, 0.092, 189, 87, CAUGHT-IN-ACTION SIGNALING COMPLEX OF RIG-I 2CARD DOMAIN AND MAVS CARD DOMAIN
158, 4p4hC, 0.6194, 2.76, 0.092, 189, 87, CAUGHT-IN-ACTION SIGNALING COMPLEX OF RIG-I 2CARD DOMAIN AND MAVS CARD DOMAIN
159, 1wmgD, 0.6193, 1.90, 0.176, 82, 74, CRYSTAL STRUCTURE OF THE UNC5H2 DEATH DOMAIN
160, 4p4hD, 0.6191, 3.01, 0.091, 188, 88, CAUGHT-IN-ACTION SIGNALING COMPLEX OF RIG-I 2CARD DOMAIN AND MAVS CARD DOMAIN
161, 4p4hH, 0.6190, 3.01, 0.091, 188, 88, CAUGHT-IN-ACTION SIGNALING COMPLEX OF RIG-I 2CARD DOMAIN AND MAVS CARD DOMAIN
162, 4p4hB, 0.6184, 2.97, 0.091, 189, 88, CAUGHT-IN-ACTION SIGNALING COMPLEX OF RIG-I 2CARD DOMAIN AND MAVS CARD DOMAIN
163, 4a2wB, 0.6180, 2.83, 0.103, 674, 87, STRUCTURE OF FULL-LENGTH DUCK RIG-I
164, 4p4hF, 0.6178, 2.98, 0.091, 189, 88, CAUGHT-IN-ACTION SIGNALING COMPLEX OF RIG-I 2CARD DOMAIN AND MAVS CARD DOMAIN
165, 4a2wA, 0.6174, 2.84, 0.103, 678, 87, STRUCTURE OF FULL-LENGTH DUCK RIG-I
166, 4nqkC, 0.6133, 2.86, 0.103, 188, 87, STRUCTURE OF AN UBIQUITIN COMPLEX
167, 6bzhD, 0.6131, 3.04, 0.114, 189, 88, STRUCTURE OF MOUSE RIG-I TANDEM CARDS
168, 1wmgF, 0.6130, 2.13, 0.184, 83, 76, CRYSTAL STRUCTURE OF THE UNC5H2 DEATH DOMAIN
169, 6bzhB, 0.6122, 2.89, 0.115, 192, 87, STRUCTURE OF MOUSE RIG-I TANDEM CARDS
170, 4fh0B, 0.6114, 2.55, 0.110, 93, 82, CRYSTAL STRUCTURE OF HUMAN BINCARD CARD DOUBLE MUTANT F16M/L66M SEMET FORM
171, 4fh0A, 0.6103, 2.52, 0.111, 93, 81, CRYSTAL STRUCTURE OF HUMAN BINCARD CARD DOUBLE MUTANT F16M/L66M SEMET FORM
172, 4a2qB, 0.6103, 2.86, 0.103, 675, 87, STRUCTURE OF DUCK RIG-I TANDEM CARDS AND HELICASE DOMAIN
173, 1c15A, 0.6101, 2.92, 0.067, 97, 90, SOLUTION STRUCTURE OF APAF-1 CARD
174, 4iz5E, 0.6099, 2.33, 0.066, 86, 76, STRUCTURE OF THE COMPLEX BETWEEN ERK2 PHOSPHOMIMETIC MUTANT AND PEA-15
175, 4iz5G, 0.6098, 2.33, 0.066, 86, 76, STRUCTURE OF THE COMPLEX BETWEEN ERK2 PHOSPHOMIMETIC MUTANT AND PEA-15
176, 4a2qA, 0.6097, 2.86, 0.103, 674, 87, STRUCTURE OF DUCK RIG-I TANDEM CARDS AND HELICASE DOMAIN
177, 4iz5H, 0.6096, 2.34, 0.066, 80, 76, STRUCTURE OF THE COMPLEX BETWEEN ERK2 PHOSPHOMIMETIC MUTANT AND PEA-15
178, 5julP, 0.6095, 3.26, 0.133, 1232, 90, 
179, 5julO, 0.6095, 3.26, 0.133, 1232, 90, 
180, 5julN, 0.6095, 3.26, 0.133, 1232, 90, 
181, 5julM, 0.6095, 3.26, 0.133, 1232, 90, 
182, 5julL, 0.6095, 3.26, 0.133, 1232, 90, 
183, 5julK, 0.6095, 3.26, 0.133, 1232, 90, 
184, 5julJ, 0.6095, 3.26, 0.133, 1232, 90, 
185, 5julI, 0.6095, 3.26, 0.133, 1232, 90, 
186, 5julH, 0.6095, 3.26, 0.133, 1232, 90, 
187, 5julG, 0.6095, 3.26, 0.133, 1232, 90, 
188, 5julF, 0.6095, 3.26, 0.133, 1232, 90, 
189, 5julE, 0.6095, 3.26, 0.133, 1232, 90, 
190, 5julD, 0.6095, 3.26, 0.133, 1232, 90, 
191, 5julC, 0.6095, 3.26, 0.133, 1232, 90, 
192, 5julB, 0.6095, 3.26, 0.133, 1232, 90, 
193, 5julA, 0.6095, 3.26, 0.133, 1232, 90, 
194, 4iz5F, 0.6095, 2.34, 0.066, 86, 76, STRUCTURE OF THE COMPLEX BETWEEN ERK2 PHOSPHOMIMETIC MUTANT AND PEA-15
195, 4o9lA, 0.6094, 2.63, 0.188, 96, 85, CRYSTAL STRUCTURE OF HORSE MAVS CARD DOMAIN MUTANT E26R
196, 2gf5A, 0.6091, 3.26, 0.809, 191, 89, STRUCTURE OF INTACT FADD (MORT1)
197, 6bzhA, 0.6090, 2.90, 0.115, 191, 87, STRUCTURE OF MOUSE RIG-I TANDEM CARDS
198, 5wveR, 0.6074, 2.63, 0.086, 91, 81, APAF-1-CASPASE-9 HOLOENZYME
199, 5wveP, 0.6074, 2.63, 0.086, 91, 81, APAF-1-CASPASE-9 HOLOENZYME
200, 5wveO, 0.6074, 2.63, 0.086, 91, 81, APAF-1-CASPASE-9 HOLOENZYME
201, 3ygsC, 0.6074, 2.63, 0.086, 95, 81, APAF-1 CARD IN COMPLEX WITH PRODOMAIN OF PROCASPASE-9
202, 2ygsA, 0.6070, 2.66, 0.086, 92, 81, CARD DOMAIN FROM APAF-1
203, 5wveX, 0.6067, 2.65, 0.086, 92, 81, APAF-1-CASPASE-9 HOLOENZYME
204, 4rhwB, 0.6067, 2.65, 0.086, 92, 81, CRYSTAL STRUCTURE OF APAF-1 CARD AND CASPASE-9 CARD COMPLEX
205, 4rhwD, 0.6062, 2.72, 0.099, 92, 81, CRYSTAL STRUCTURE OF APAF-1 CARD AND CASPASE-9 CARD COMPLEX
206, 1z6tD, 0.6058, 2.62, 0.086, 576, 81, STRUCTURE OF THE APOPTOTIC PROTEASE-ACTIVATING FACTOR 1 BOUND TO ADP
207, 5wveQ, 0.6056, 2.64, 0.086, 91, 81, APAF-1-CASPASE-9 HOLOENZYME
208, 1z6tA, 0.6055, 2.62, 0.086, 576, 81, STRUCTURE OF THE APOPTOTIC PROTEASE-ACTIVATING FACTOR 1 BOUND TO ADP
209, 1z6tC, 0.6044, 2.56, 0.098, 586, 82, STRUCTURE OF THE APOPTOTIC PROTEASE-ACTIVATING FACTOR 1 BOUND TO ADP
210, 1z6tB, 0.6043, 2.56, 0.098, 586, 82, STRUCTURE OF THE APOPTOTIC PROTEASE-ACTIVATING FACTOR 1 BOUND TO ADP
211, 5wvcC, 0.6041, 2.65, 0.086, 95, 81, STRUCTURE OF THE CARD-CARD DISK
212, 3j63K, 0.6031, 2.45, 0.112, 91, 80, UNIFIED ASSEMBLY MECHANISM OF ASC-DEPENDENT INFLAMMASOMES
213, 3j63D, 0.6025, 2.46, 0.112, 91, 80, UNIFIED ASSEMBLY MECHANISM OF ASC-DEPENDENT INFLAMMASOMES
214, 2n1fO, 0.6024, 2.36, 0.103, 89, 78, STRUCTURE AND ASSEMBLY OF THE MOUSE ASC FILAMENT BY COMBINED NMR SPECTROSCOPY AND CRYO-ELECTRON MICROSCOPY
215, 2n1fN, 0.6024, 2.36, 0.103, 89, 78, STRUCTURE AND ASSEMBLY OF THE MOUSE ASC FILAMENT BY COMBINED NMR SPECTROSCOPY AND CRYO-ELECTRON MICROSCOPY
216, 2n1fM, 0.6024, 2.36, 0.103, 89, 78, STRUCTURE AND ASSEMBLY OF THE MOUSE ASC FILAMENT BY COMBINED NMR SPECTROSCOPY AND CRYO-ELECTRON MICROSCOPY
217, 2n1fL, 0.6024, 2.36, 0.103, 89, 78, STRUCTURE AND ASSEMBLY OF THE MOUSE ASC FILAMENT BY COMBINED NMR SPECTROSCOPY AND CRYO-ELECTRON MICROSCOPY
218, 2n1fK, 0.6024, 2.36, 0.103, 89, 78, STRUCTURE AND ASSEMBLY OF THE MOUSE ASC FILAMENT BY COMBINED NMR SPECTROSCOPY AND CRYO-ELECTRON MICROSCOPY
219, 2n1fJ, 0.6024, 2.36, 0.103, 89, 78, STRUCTURE AND ASSEMBLY OF THE MOUSE ASC FILAMENT BY COMBINED NMR SPECTROSCOPY AND CRYO-ELECTRON MICROSCOPY
220, 2n1fI, 0.6024, 2.36, 0.103, 89, 78, STRUCTURE AND ASSEMBLY OF THE MOUSE ASC FILAMENT BY COMBINED NMR SPECTROSCOPY AND CRYO-ELECTRON MICROSCOPY
221, 2n1fH, 0.6024, 2.36, 0.103, 89, 78, STRUCTURE AND ASSEMBLY OF THE MOUSE ASC FILAMENT BY COMBINED NMR SPECTROSCOPY AND CRYO-ELECTRON MICROSCOPY
222, 2n1fG, 0.6024, 2.36, 0.103, 89, 78, STRUCTURE AND ASSEMBLY OF THE MOUSE ASC FILAMENT BY COMBINED NMR SPECTROSCOPY AND CRYO-ELECTRON MICROSCOPY
223, 2n1fF, 0.6024, 2.36, 0.103, 89, 78, STRUCTURE AND ASSEMBLY OF THE MOUSE ASC FILAMENT BY COMBINED NMR SPECTROSCOPY AND CRYO-ELECTRON MICROSCOPY
224, 2n1fE, 0.6024, 2.36, 0.103, 89, 78, STRUCTURE AND ASSEMBLY OF THE MOUSE ASC FILAMENT BY COMBINED NMR SPECTROSCOPY AND CRYO-ELECTRON MICROSCOPY
225, 2n1fD, 0.6024, 2.36, 0.103, 89, 78, STRUCTURE AND ASSEMBLY OF THE MOUSE ASC FILAMENT BY COMBINED NMR SPECTROSCOPY AND CRYO-ELECTRON MICROSCOPY
226, 2n1fC, 0.6024, 2.36, 0.103, 89, 78, STRUCTURE AND ASSEMBLY OF THE MOUSE ASC FILAMENT BY COMBINED NMR SPECTROSCOPY AND CRYO-ELECTRON MICROSCOPY
227, 2n1fB, 0.6024, 2.36, 0.103, 89, 78, STRUCTURE AND ASSEMBLY OF THE MOUSE ASC FILAMENT BY COMBINED NMR SPECTROSCOPY AND CRYO-ELECTRON MICROSCOPY
228, 2n1fA, 0.6024, 2.36, 0.103, 89, 78, STRUCTURE AND ASSEMBLY OF THE MOUSE ASC FILAMENT BY COMBINED NMR SPECTROSCOPY AND CRYO-ELECTRON MICROSCOPY
229, 2n00A, 0.6023, 3.28, 0.100, 95, 90, NMR SOLUTION STRUCTURE OF AIM2 PYD FROM MUS MUSCULUS
230, 3j63C, 0.6020, 2.46, 0.112, 91, 80, UNIFIED ASSEMBLY MECHANISM OF ASC-DEPENDENT INFLAMMASOMES
231, 3j63I, 0.6016, 2.45, 0.112, 91, 80, UNIFIED ASSEMBLY MECHANISM OF ASC-DEPENDENT INFLAMMASOMES
232, 3j63A, 0.6015, 2.46, 0.112, 91, 80, UNIFIED ASSEMBLY MECHANISM OF ASC-DEPENDENT INFLAMMASOMES
233, 3j63O, 0.6014, 2.46, 0.112, 91, 80, UNIFIED ASSEMBLY MECHANISM OF ASC-DEPENDENT INFLAMMASOMES
234, 3j63J, 0.6013, 2.46, 0.112, 91, 80, UNIFIED ASSEMBLY MECHANISM OF ASC-DEPENDENT INFLAMMASOMES
235, 3j63H, 0.6013, 2.46, 0.112, 91, 80, UNIFIED ASSEMBLY MECHANISM OF ASC-DEPENDENT INFLAMMASOMES
236, 3j63N, 0.6011, 2.46, 0.112, 91, 80, UNIFIED ASSEMBLY MECHANISM OF ASC-DEPENDENT INFLAMMASOMES
237, 5wvcA, 0.6009, 2.68, 0.086, 95, 81, STRUCTURE OF THE CARD-CARD DISK
238, 4o9fA, 0.6008, 2.76, 0.212, 94, 85, CRYSTAL STRUCTURE OF HORSE MAVS CARD DOMAIN MUTANT R64C
239, 3j63M, 0.6008, 2.46, 0.112, 91, 80, UNIFIED ASSEMBLY MECHANISM OF ASC-DEPENDENT INFLAMMASOMES
240, 5wvcE, 0.6005, 2.66, 0.086, 94, 81, STRUCTURE OF THE CARD-CARD DISK
241, 3j63L, 0.6005, 2.47, 0.112, 91, 80, UNIFIED ASSEMBLY MECHANISM OF ASC-DEPENDENT INFLAMMASOMES
242, 3j63G, 0.6005, 2.47, 0.112, 91, 80, UNIFIED ASSEMBLY MECHANISM OF ASC-DEPENDENT INFLAMMASOMES
243, 3j63F, 0.6004, 2.47, 0.112, 91, 80, UNIFIED ASSEMBLY MECHANISM OF ASC-DEPENDENT INFLAMMASOMES
244, 3j63E, 0.5997, 2.47, 0.112, 91, 80, UNIFIED ASSEMBLY MECHANISM OF ASC-DEPENDENT INFLAMMASOMES
245, 4a2qE, 0.5993, 2.95, 0.103, 670, 87, STRUCTURE OF DUCK RIG-I TANDEM CARDS AND HELICASE DOMAIN
246, 4a2qD, 0.5993, 2.95, 0.103, 671, 87, STRUCTURE OF DUCK RIG-I TANDEM CARDS AND HELICASE DOMAIN
247, 3j63B, 0.5989, 2.47, 0.112, 91, 80, UNIFIED ASSEMBLY MECHANISM OF ASC-DEPENDENT INFLAMMASOMES
248, 4lwdA, 0.5959, 2.60, 0.120, 90, 83, HUMAN CARMA1 CARD DOMAIN
249, 2p1hA, 0.5959, 2.76, 0.086, 94, 81, RAPID FOLDING AND UNFOLDING OF APAF-1 CARD
250, 1ucpA, 0.5956, 2.51, 0.112, 91, 80, NMR STRUCTURE OF THE PYRIN DOMAIN OF HUMAN ASC
251, 4i16A, 0.5950, 2.55, 0.110, 90, 82, CRYSTAL STRUCTURE OF CARMA1 CARD
252, 1cy5A, 0.5949, 2.73, 0.086, 92, 81, CRYSTAL STRUCTURE OF THE APAF-1 CARD
253, 5ldeA, 0.5943, 2.54, 0.145, 221, 76, CRYSTAL STRUCTURE OF A VFLIP-IKKGAMMA STAPLED PEPTIDE DIMER
254, 3j9lP, 0.5941, 3.36, 0.121, 1063, 91, 
255, 3j9lO, 0.5941, 3.36, 0.121, 1062, 91, 
256, 3j9lN, 0.5941, 3.36, 0.121, 1062, 91, 
257, 3j9lM, 0.5941, 3.36, 0.121, 1062, 91, 
258, 3j9lL, 0.5941, 3.36, 0.121, 1062, 91, 
259, 3j9lK, 0.5941, 3.36, 0.121, 1062, 91, 
260, 3j9lJ, 0.5941, 3.36, 0.121, 1062, 91, 
261, 3j9lI, 0.5941, 3.36, 0.121, 1062, 91, 
262, 3j9lH, 0.5941, 3.36, 0.121, 1062, 91, 
263, 3j9lG, 0.5941, 3.36, 0.121, 1062, 91, 
264, 3j9lF, 0.5941, 3.36, 0.121, 1062, 91, 
265, 3j9lE, 0.5941, 3.36, 0.121, 1062, 91, 
266, 3j9lD, 0.5941, 3.36, 0.121, 1062, 91, 
267, 3j9lC, 0.5941, 3.36, 0.121, 1062, 91, 
268, 3j9lB, 0.5941, 3.36, 0.121, 1062, 91, 
269, 3j9lA, 0.5941, 3.36, 0.121, 1062, 91, 
270, 1wmgA, 0.5939, 2.34, 0.169, 86, 77, CRYSTAL STRUCTURE OF THE UNC5H2 DEATH DOMAIN
271, 3qf2B, 0.5931, 2.58, 0.076, 106, 79, CRYSTAL STRUCTURE OF NALP3 PYD
272, 5wveW, 0.5930, 2.73, 0.086, 95, 81, APAF-1-CASPASE-9 HOLOENZYME
273, 4rhwA, 0.5930, 2.73, 0.086, 95, 81, CRYSTAL STRUCTURE OF APAF-1 CARD AND CASPASE-9 CARD COMPLEX
274, 3qf2A, 0.5905, 2.48, 0.064, 90, 78, CRYSTAL STRUCTURE OF NALP3 PYD
275, 5ldeB, 0.5901, 2.62, 0.145, 225, 76, CRYSTAL STRUCTURE OF A VFLIP-IKKGAMMA STAPLED PEPTIDE DIMER
276, 2lweA, 0.5898, 3.00, 0.098, 96, 82, SOLUTION STRUCTURE OF MUTANT (T170E) SECOND CARD OF HUMAN RIG-I
277, 4rhwC, 0.5891, 2.75, 0.086, 95, 81, CRYSTAL STRUCTURE OF APAF-1 CARD AND CASPASE-9 CARD COMPLEX
278, 2dbdA, 0.5885, 2.82, 0.131, 107, 84, SOLUTION STRUCTURE OF THE CARD DOMAIN IN HUMAN CASPASE RECRUITMENT DOMAIN PROTEIN 4 (NOD1 PROTEIN)
279, 3j9kY, 0.5873, 3.35, 0.135, 1063, 89, 
280, 3j9kW, 0.5873, 3.35, 0.135, 1063, 89, 
281, 3j9kU, 0.5873, 3.35, 0.135, 1063, 89, 
282, 3j9kS, 0.5873, 3.35, 0.135, 1063, 89, 
283, 3j9kQ, 0.5873, 3.35, 0.135, 1063, 89, 
284, 3j9kO, 0.5873, 3.35, 0.135, 1063, 89, 
285, 3j9kM, 0.5873, 3.35, 0.135, 1063, 89, 
286, 3j9kK, 0.5873, 3.35, 0.135, 1063, 89, 
287, 3j9kI, 0.5873, 3.35, 0.135, 1063, 89, 
288, 3j9kG, 0.5873, 3.35, 0.135, 1063, 89, 
289, 3j9kEA, 0.5873, 3.35, 0.135, 1063, 89, 
290, 3j9kE, 0.5873, 3.35, 0.135, 1063, 89, 
291, 3j9kCA, 0.5873, 3.35, 0.135, 1063, 89, 
292, 3j9kC, 0.5873, 3.35, 0.135, 1063, 89, 
293, 3j9kAA, 0.5873, 3.35, 0.135, 1063, 89, 
294, 3j9kA, 0.5873, 3.35, 0.135, 1063, 89, 
295, 2km6A, 0.5863, 3.35, 0.135, 1063, 89, NMR STRUCTURE OF THE NLRP7 PYRIN DOMAIN
296, 2mpcA, 0.5855, 3.35, 0.135, 1063, 89, SOLUTION STRUCTURE OF THE PYRIN DOMAIN OF HUMAN PYRIN
297, 3cl3A, 0.5854, 3.35, 0.135, 1063, 89, CRYSTAL STRUCTURE OF A VFLIP-IKKGAMMA COMPLEX: INSIGHTS INTO VIRAL ACTIVATION OF THE IKK SIGNALOSOME
298, 1a1zA, 0.5847, 3.01, 0.120, 96, 83, FADD DEATH EFFECTOR DOMAIN F25G MUTANT NMR MINIMIZED AVERAGE STRUCTURE
299, 1wmgB, 0.5811, 2.56, 0.137, 90, 80, CRYSTAL STRUCTURE OF THE UNC5H2 DEATH DOMAIN
300, 3cl3B, 0.5799, 2.64, 0.147, 172, 75, CRYSTAL STRUCTURE OF A VFLIP-IKKGAMMA COMPLEX: INSIGHTS INTO VIRAL ACTIVATION OF THE IKK SIGNALOSOME
301, 2l6aA, 0.5799, 2.60, 0.091, 83, 77, THREE-DIMENSIONAL STRUCTURE OF THE N-TERMINAL EFFECTOR PYRIN DOMAIN OF NLRP12
302, 3t6pA, 0.5784, 1.98, 0.183, 79, 71, IAP ANTAGONIST-INDUCED CONFORMATIONAL CHANGE IN CIAP1 PROMOTES E3 LIGASE ACTIVATION VIA DIMERIZATION
303, 2n7zA, 0.5765, 2.44, 0.151, 165, 73, SOLUTION STRUCTURE OF RIP2 CARD
304, 3crdA, 0.5759, 2.83, 0.065, 102, 77, NMR STRUCTURE OF THE RAIDD CARD DOMAIN 15 STRUCTURES
305, 2n83A, 0.5757, 3.09, 0.096, 330, 83, P75NTR DD:RIP2 CARD
306, 4jupA, 0.5740, 3.41, 0.126, 106, 87, DIMERIC STRUCTURE OF CARMA1 CARD
307, 2kn6A, 0.5727, 3.47, 0.111, 100, 90, STRUCTURE OF FULL-LENGTH HUMAN ASC (APOPTOSIS-ASSOCIATED SPECK-LIKE PROTEIN CONTAINING A CARD)
308, 4jupB, 0.5720, 3.09, 0.259, 94, 81, DIMERIC STRUCTURE OF CARMA1 CARD
309, 4qobA, 0.5715, 2.37, 0.118, 80, 76, CRYSTAL STRUCTURE OF CPOP1
310, 3ezqK, 0.5711, 2.82, 0.110, 195, 82, CRYSTAL STRUCTURE OF THE FAS/FADD DEATH DOMAIN COMPLEX
311, 3ezqO, 0.5710, 2.24, 0.122, 80, 74, CRYSTAL STRUCTURE OF THE FAS/FADD DEATH DOMAIN COMPLEX
312, 3ezqM, 0.5688, 2.41, 0.132, 87, 76, CRYSTAL STRUCTURE OF THE FAS/FADD DEATH DOMAIN COMPLEX
313, 3ezqE, 0.5688, 3.32, 0.192, 115, 78, CRYSTAL STRUCTURE OF THE FAS/FADD DEATH DOMAIN COMPLEX
314, 3ezqA, 0.5687, 3.39, 0.190, 115, 79, CRYSTAL STRUCTURE OF THE FAS/FADD DEATH DOMAIN COMPLEX
315, 3ezqG, 0.5684, 2.95, 0.197, 115, 76, CRYSTAL STRUCTURE OF THE FAS/FADD DEATH DOMAIN COMPLEX
316, 4ewiA, 0.5682, 2.95, 0.197, 115, 76, CRYSTAL STRUCTURE OF THE NLRP4 PYRIN DOMAIN
317, 3ezqI, 0.5682, 3.06, 0.195, 115, 77, CRYSTAL STRUCTURE OF THE FAS/FADD DEATH DOMAIN COMPLEX
318, 3ezqC, 0.5682, 3.06, 0.195, 115, 77, CRYSTAL STRUCTURE OF THE FAS/FADD DEATH DOMAIN COMPLEX
319, 4qobB, 0.5679, 2.79, 0.104, 91, 77, CRYSTAL STRUCTURE OF CPOP1
320, 4uz0A, 0.5675, 3.06, 0.195, 115, 77, CRYSTAL STRUCTURE OF APOPTOSIS REPRESSOR WITH CARD (ARC)
321, 2l9mA, 0.5668, 3.06, 0.195, 115, 77, STRUCTURE OF CIAP1 CARD
322, 2hm2Q, 0.5664, 2.40, 0.118, 87, 76, SOLUTION STRUCTURE OF ASC2
323, 5juyG, 0.5617, 2.79, 0.165, 86, 79, ACTIVE HUMAN APOPTOSOME WITH PROCASPASE-9
324, 2g7rB, 0.5615, 2.89, 0.083, 132, 84, X-RAY STRUCTURE OF THE DEATH DOMAIN OF THE HUMAN MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA TRANSLOCATION PROTEIN 1
325, 1a1wA, 0.5613, 2.63, 0.128, 89, 78, FADD DEATH EFFECTOR DOMAIN F25Y MUTANT NMR MINIMIZED AVERAGE STRUCTURE
326, 2g7rA, 0.5609, 3.12, 0.084, 1234, 83, X-RAY STRUCTURE OF THE DEATH DOMAIN OF THE HUMAN MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA TRANSLOCATION PROTEIN 1
327, 1pn5A, 0.5604, 2.93, 0.149, 86, 74, NMR STRUCTURE OF THE NALP1 PYRIN DOMAIN (PYD)
328, 5juyE, 0.5598, 2.61, 0.091, 83, 77, ACTIVE HUMAN APOPTOSOME WITH PROCASPASE-9
329, 5juyD, 0.5598, 2.94, 0.149, 86, 74, ACTIVE HUMAN APOPTOSOME WITH PROCASPASE-9
330, 5juyB, 0.5598, 3.05, 0.078, 93, 77, ACTIVE HUMAN APOPTOSOME WITH PROCASPASE-9
331, 4e9mD, 0.5595, 2.98, 0.072, 1234, 83, NOD1 CARD DOMAIN WITH THREE DISULFIDE-CLINCHED DOMAIN-SWAPPED DIMERS IN THE ASYMMETRIC UNIT
332, 4ewiB, 0.5564, 2.98, 0.072, 1234, 83, CRYSTAL STRUCTURE OF THE NLRP4 PYRIN DOMAIN
333, 2nsnA, 0.5557, 2.98, 0.072, 1234, 83, CRYSTAL STRUCTURE OF CASPACE ACTIVATION AND RECRUITMENT DOMAIN (CARD) OF NOD1
334, 2lwdA, 0.5556, 2.32, 0.137, 95, 73, SOLUTION STRUCTURE OF SECOND CARD OF HUMAN RIG-I
335, 2nz7A, 0.5555, 2.57, 0.107, 90, 75, CRYSTAL STRUCTURE ANALYSIS OF CASPASE-RECRUITMENT DOMAIN (CARD) OF NOD1
336, 4jqwA, 0.5538, 2.56, 0.135, 95, 74, CRYSTAL STRUCTURE OF A COMPLEX OF NOD1 CARD AND UBIQUITIN
337, 4e9mA, 0.5535, 3.39, 0.084, 96, 83, NOD1 CARD DOMAIN WITH THREE DISULFIDE-CLINCHED DOMAIN-SWAPPED DIMERS IN THE ASYMMETRIC UNIT
338, 2nz7B, 0.5530, 2.37, 0.137, 93, 73, CRYSTAL STRUCTURE ANALYSIS OF CASPASE-RECRUITMENT DOMAIN (CARD) OF NOD1
339, 4e9mB, 0.5528, 2.52, 0.137, 91, 73, NOD1 CARD DOMAIN WITH THREE DISULFIDE-CLINCHED DOMAIN-SWAPPED DIMERS IN THE ASYMMETRIC UNIT
340, 4e9mC, 0.5517, 2.59, 0.135, 97, 74, NOD1 CARD DOMAIN WITH THREE DISULFIDE-CLINCHED DOMAIN-SWAPPED DIMERS IN THE ASYMMETRIC UNIT
341, 4e9mE, 0.5513, 2.37, 0.137, 98, 73, NOD1 CARD DOMAIN WITH THREE DISULFIDE-CLINCHED DOMAIN-SWAPPED DIMERS IN THE ASYMMETRIC UNIT
342, 5fnaH, 0.5498, 2.59, 0.135, 95, 74, CRYO-EM RECONSTRUCTION OF CASPASE-1 CARD
343, 5fnaG, 0.5498, 2.57, 0.135, 91, 74, CRYO-EM RECONSTRUCTION OF CASPASE-1 CARD
344, 5fnaF, 0.5498, 2.68, 0.122, 87, 74, CRYO-EM RECONSTRUCTION OF CASPASE-1 CARD
345, 5fnaE, 0.5498, 2.74, 0.064, 85, 78, CRYO-EM RECONSTRUCTION OF CASPASE-1 CARD
346, 5fnaD, 0.5498, 2.74, 0.064, 85, 78, CRYO-EM RECONSTRUCTION OF CASPASE-1 CARD
347, 5fnaC, 0.5498, 2.74, 0.064, 85, 78, CRYO-EM RECONSTRUCTION OF CASPASE-1 CARD
348, 5fnaB, 0.5498, 2.74, 0.064, 85, 78, CRYO-EM RECONSTRUCTION OF CASPASE-1 CARD
349, 5fnaA, 0.5498, 2.74, 0.064, 85, 78, CRYO-EM RECONSTRUCTION OF CASPASE-1 CARD
350, 2ib1A, 0.5471, 2.74, 0.064, 85, 78, SOLUTION STRUCTURE OF P45 DEATH DOMAIN
351, 4e9mF, 0.5465, 2.74, 0.064, 85, 78, NOD1 CARD DOMAIN WITH THREE DISULFIDE-CLINCHED DOMAIN-SWAPPED DIMERS IN THE ASYMMETRIC UNIT
352, 2n83B, 0.5394, 2.74, 0.064, 85, 78, P75NTR DD:RIP2 CARD
353, 2do9A, 0.5366, 3.02, 0.179, 91, 78, SOLUTION STRUCTURE OF THE PYRIN/PAAD-DAPIN DOMAIN IN MOUSE NALP10 (NACHT LEUCINE RICH REPEAT AND PYD CONTAINING 10)
354, 1cwwA, 0.5361, 2.67, 0.135, 94, 74, SOLUTION STRUCTURE OF THE CASPASE RECRUITMENT DOMAIN (CARD) FROM APAF-1
355, 2b1wA, 0.5360, 3.26, 0.123, 105, 81, SOLUTION STRUCTURE OF THE NOD1 CASPASE ACTIVATING AND RECRUITMENT DOMAIN
356, 4uz0B, 0.5304, 3.08, 0.090, 115, 78, CRYSTAL STRUCTURE OF APOPTOSIS REPRESSOR WITH CARD (ARC)
357, 2m5vA, 0.5195, 3.34, 0.098, 102, 82, THREE-DIMENSIONAL STRUCTURE OF HUMAN NLRP10/PYNOD PYRIN DOMAIN
358, 2dbhA, 0.5161, 3.42, 0.048, 99, 84, SOLUTION STRUCTURE OF THE CARBOXYL-TERMINAL CARD-LIKE DOMAIN IN HUMAN TNFR-RELATED DEATH RECEPTOR-6
359, 4n1kD, 0.5116, 2.50, 0.167, 79, 72, CRYSTAL STRUCTURES OF NLRP14 PYRIN DOMAIN REVEAL A CONFORMATIONAL SWITCH MECHANISM REGULATING ITS MOLECULAR INTERACTIONS
360, 2yu0A, 0.5113, 3.59, 0.084, 102, 83, SOLUTION STRUCTURES OF THE PAAD_DAPIN DOMAIN OF MUS MUSCULUS INTERFERON-ACTIVATABLE PROTEIN 205
361, 6bw6A, 0.5105, 3.69, 0.087, 102, 80, HUMAN GPT (DPAGT1) H129 VARIANT IN COMPLEX WITH TUNICAMYCIN
362, 6bw5A, 0.5099, 2.75, 0.072, 94, 69, HUMAN GPT (DPAGT1) IN COMPLEX WITH TUNICAMYCIN
363, 6bw5B, 0.5092, 3.34, 0.038, 94, 78, HUMAN GPT (DPAGT1) IN COMPLEX WITH TUNICAMYCIN
364, 6bw6D, 0.5089, 3.42, 0.037, 368, 81, HUMAN GPT (DPAGT1) H129 VARIANT IN COMPLEX WITH TUNICAMYCIN
365, 6bw6C, 0.5088, 3.80, 0.024, 378, 82, HUMAN GPT (DPAGT1) H129 VARIANT IN COMPLEX WITH TUNICAMYCIN
366, 6bw5D, 0.5083, 3.44, 0.037, 369, 81, HUMAN GPT (DPAGT1) IN COMPLEX WITH TUNICAMYCIN
367, 6bw5C, 0.5079, 3.43, 0.037, 369, 81, HUMAN GPT (DPAGT1) IN COMPLEX WITH TUNICAMYCIN
368, 6bw6B, 0.5075, 3.42, 0.037, 365, 81, HUMAN GPT (DPAGT1) H129 VARIANT IN COMPLEX WITH TUNICAMYCIN
369, 6fwzA, 0.5070, 3.47, 0.049, 362, 81, CRYSTAL STRUCTURE OF HUMAN UDP-N-ACETYLGLUCOSAMINE-DOLICHYL-PHOSPHATE N-ACETYLGLUCOSAMINEPHOSPHOTRANSFERASE (DPAGT1) (V264G MUTANT) IN COMPLEX WITH UDP-GLCNAC 
370, 4n1kC, 0.5046, 3.39, 0.025, 375, 79, CRYSTAL STRUCTURES OF NLRP14 PYRIN DOMAIN REVEAL A CONFORMATIONAL SWITCH MECHANISM REGULATING ITS MOLECULAR INTERACTIONS
371, 5o5eA, 0.5037, 3.23, 0.039, 374, 76, CRYSTAL STRUCTURE OF HUMAN UDP-N-ACETYLGLUCOSAMINE-DOLICHYL-PHOSPHATE N-ACETYLGLUCOSAMINEPHOSPHOTRANSFERASE (DPAGT1) (V264G MUTANT) IN COMPLEX WITH TUNICAMYCIN
372, 4n1kB, 0.5029, 3.31, 0.013, 373, 79, CRYSTAL STRUCTURES OF NLRP14 PYRIN DOMAIN REVEAL A CONFORMATIONAL SWITCH MECHANISM REGULATING ITS MOLECULAR INTERACTIONS
373, 5levA, 0.5015, 2.74, 0.074, 86, 68, CRYSTAL STRUCTURE OF HUMAN UDP-N-ACETYLGLUCOSAMINE-DOLICHYL-PHOSPHATE N-ACETYLGLUCOSAMINEPHOSPHOTRANSFERASE (DPAGT1) (V264G MUTANT)
374, 2naqA, 0.5014, 3.25, 0.053, 381, 76, 3D NMR SOLUTION STRUCTURE OF NLRP3 PYD
375, 6fm9A, 0.5012, 2.75, 0.074, 92, 68, CRYSTAL STRUCTURE OF HUMAN UDP-N-ACETYLGLUCOSAMINE-DOLICHYL-PHOSPHATE N-ACETYLGLUCOSAMINEPHOSPHOTRANSFERASE (DPAGT1)
376, 4n1kA, 0.5009, 3.24, 0.039, 375, 76, CRYSTAL STRUCTURES OF NLRP14 PYRIN DOMAIN REVEAL A CONFORMATIONAL SWITCH MECHANISM REGULATING ITS MOLECULAR INTERACTIONS
